Product Matches
- Z4833ZM-336372
c-Raf activator, tyrosine kinase inhibitor.
≥98% - S0224SAG
Smoothened agonist.
≥98% - I5357Inositol
Endogenous sugar produced from glucose, required for production of IMP and ph...
≥98% - P2817Phentolamine Hydrochloride
ATP-sensitive K+ channel activator, α-adrenergic antagonist.
≥98% - A7578Astragaloside IV
Found in Astragalus membranaceus.
≥98% - G8850GW-5074
c-Raf inhibitor.
≥98% - Proteasomal Activation by Palbociclib In Advanced Breast CancerPalbociclib is a chemotherapy drug used to treat advanced breast cancers. In a p...
- T1733Teicoplanin
Glycopeptide, vancomycin analog; peptidoglycan formation inhibitor. ≥900 ug...
≥900 ug/mg, bio assay - New Product Spotlight: The anticancer agent PAC-1PAC-1 (Procaspase activating compound 1) is an anti-cancer compound that works a...
- C4759Clozapine N-oxide
Inert clozapine analog, activates specialized GPCRs.
≥98% - B68574’-Bromoflavone
Nrf2-Keap1-ARE complex activator.
≥98% - P7059Proxymetacaine Hydrochloride
Potential voltage-gated Na+ channel blocker.
≥98% - S8151Sumatriptan Succinate
Tryptamine; 5-HT1B/1D agonist, TRPV1 antagonist.
≥99% - M1564S-Methyl-L-cysteine
Antioxidant found in Brassicaceae family plants.
≥99% - C0365Carvedilol
FIASMA; α1- and β1/2-adrenergic antagonist.
≥98% - D1767Dermenkephalin
Exogenous peptide; δOR-2 agonist.
≥95% - Y1000Y27632 Dihydrochloride
ROCK inhibitor.
≥99% - Oxytocin Innovations and an FDA-approved Peptide DatabasePeptides and proteins as therapeutics have the advantage over other drugs of usi...
- M5727Moguisteine
Potential ATP-sensitive K+ channel blocker, potential irritant receptor antag...
≥98% - U6857Urodilatin CCC
ANP fragment, natriuretic peptide; Na+/K+ ATPase inhibitor.
≥98%